CLEO Diagnostics Ltd (AU:COV) has released an update.
Cleo Diagnostics Ltd, listed on the ASX as COV, announced that all resolutions at its Annual General Meeting were passed, reflecting strong shareholder support for the company’s management and future plans. Key resolutions included re-election of directors and approval of a 10% placement facility, highlighting investor confidence in Cleo Diagnostics’ strategic direction.
For further insights into AU:COV stock, check out TipRanks’ Stock Analysis page.
